According to Matinas BioPharma's latest financial reports the company's total assets are $19.61 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $44.81 M | -26.92% |
2021-12-31 | $61.32 M | -13.59% |
2020-12-31 | $70.96 M | 76.36% |
2019-12-31 | $40.24 M | 101.77% |
2018-12-31 | $19.94 M | 38.27% |
2017-12-31 | $14.42 M | 46.94% |
2016-12-31 | $9.81 M | 16.78% |
2015-12-31 | $8.4 M | 150.07% |
2014-12-31 | $3.36 M | -70.34% |
2013-12-31 | $11.33 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.35 B | 1,688.81% | ๐บ๐ธ USA |